Navigation Links
Physicians Will Benefit from Medical Software Advice Website
Date:12/18/2007

citly request more information about their products. Market leaders such as McKesson Practice Partner and Greenway Medical are participating in the Medical Software Advice website.

Participating vendors serve a wide range of practice sizes, including solo practitioners, group practices and managed service organizations (MSOs), as well as medical specialties ranging from family practices to bariatric medicine. Participating vendors also cover the full range of application capabilities, including EMRs, medical billing, patient scheduling and complete practice management systems.

Medical Software Advice is online at www.softwareadvice.com/medical.

About Software Advice
Software Advice helps businesses in the construction, medical and retail industries make the right technology decisions. Using the Software Advice website, buyers can identify and compare software products that meet their unique requirements. After building a "short list" of best-fit products, buyers can request demonstrations, price quotes and other information. Software Advice can be found on the Web at www.softwareadvice.com. The company is headquartered in Big Sky, Montana.


'/>"/>
Contact: Don Fornes
don@softwareadvice.com
415-516-1769
Source:Eurekalert

Page: 1 2

Related medicine technology :

1. Mayo Clinic Physicians Report Findings from Research on Sleep Disorders
2. Bayer Issues Additional Guidance to Physicians on Trasylol(R)
3. Leading Physicians Present Interim Results from Multi-Center Studies of VNUS ClosureFAST Catheter at VEITHsymposium
4. Progesterone Therapy and Preterm Birth: More Evidence Helps Identify Women Who Can Benefit
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Poniard Pharmaceuticals Announces Updated Results of Picoplatin Phase 2 Trial Demonstrating Survival Benefit in Small Cell Lung Cancer Patients
7. Kosans Second-Generation Hsp90 Inhibitor, Alvespimycin, Shows 42% Clinical Benefit in Phase 1 HER2-Positive Metastatic Breast Cancer Trial
8. Statement by KCP Chairman Dr. Edward Jones in Response to FDA Advisory Committee on Benefits and Risks of Erythropoietin-Stimulating Agents in Treatment of Kidney Patients
9. Genetic Differences Predict Anti-Inflammatory Benefits From Nutritional Products
10. Evidence of Benefit Lacking for Many Common Ways of Treating Osteoarthritis of the Knee
11. Clinical Benefits Demonstrated with Low-Dose GATTEX(TM) in Phase 3 Short Bowel Syndrome Study
Post Your Comments:
*Name:
*Comment:
*Email: